CLINICAL_TRIALS trial_result · 2025-06-06

Clinical Trial Update: Examining the Effects of Neuromodulation on Glucose Metabolism in Type 2 Diabetes [NA]

This terminated clinical trial examined the effects of neuromodulation on glucose metabolism in Type 2 diabetes. Results were posted on 2025-06-06.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Scion NeuroStim | Conditions: Type 2 Diabetes | NA | Status: TERMINATED | Results posted: 2025-06-06